Sumant Kulkarni

Canaccord Genuity | Healthcare

Sumant Kulkarni is an analyst from Canaccord Genuity specializing in the Healthcare sector. Ranked #704 out of 4728 analysts, they have issued 32 stock ratings with a success rate of 81.96% and an average return of 35.69%.

Sumant Kulkarni has a well-established track record, with 32 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 81.96% and an average return of 35.69%, underscoring their expertise and ability to identify winning opportunities for investors.

#704

Out of 4728

32

Total Ratings

+81.96%

Success Rate

+35.69%

Average Return

Recent Ratings Analysis

ATAI

Jul 16, 2026

Target

$8.00

Current

$7.15

Performance

0.00%

Sumant Kulkarni rated ATAI as Hold on Jul 16, 2026, setting a price target of 8. The Hold stance appears justified, as shares hovered around 7.15 with a 0.00% move.

HELP

Jul 01, 2026

Target

$42.00

Current

$7.04

Performance

12.10%

On Jul 01, 2026, HELP was given a Buy rating by Sumant Kulkarni, with a target price of 42. The stock rallied 12.10% after the rating, narrowing the gap to the target of 42 and validating the bullish stance.

DFTX

Jun 30, 2026

Target

$58.00

Current

$44.10

Performance

-6.25%

DFTX received a Buy rating from Sumant Kulkarni on Jun 30, 2026, aiming for 58. The rating hasn’t played out as hoped, with the stock trading 6.25% below expectations.

ACAD

Jun 29, 2026

Target

$36.00

Current

$25.63

Performance

1.71%

On Jun 29, 2026, Sumant Kulkarni published a Buy outlook on ACAD, with a target of 36. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 25.63.

CMPS

Jun 26, 2026

Target

$20.00

Current

$12.43

Performance

-16.13%

Sumant Kulkarni on Jun 26, 2026 assigned CMPS a Buy rating, with a price target of 20. The call has struggled to gain traction, with shares losing 16.13%.

ZVRA

Jun 11, 2026

Target

$29.00

Current

$12.76

Performance

-1.62%

On Jun 11, 2026, Sumant Kulkarni reaffirmed ZVRA with a Buy rating, targeting 29. Market indecision has kept the 29 target in a holding pattern.

ANVS

Apr 14, 2026

Target

$17.00

Current

$1.74

Performance

0.58%

ANVS was rated Buy by Sumant Kulkarni on Apr 14, 2026, with a price objective of 17. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

NBIX

Apr 07, 2026

Target

$200.00

Current

$171.55

Performance

31.05%

On Apr 07, 2026, Sumant Kulkarni initiated coverage on NBIX with a Buy rating and target of 200. The stock’s climb of 31.05% since the call highlights the foresight in the rating.

BIIB

Apr 01, 2026

Target

$245.00

Current

$208.92

Performance

13.68%

Sumant Kulkarni issued a Buy recommendation for BIIB on Apr 01, 2026, price target set at 245. Investors following the Buy call captured upside momentum, with shares now at 208.92.

STOK

Mar 20, 2026

Target

$60.00

Current

$29.11

Performance

-13.13%

On Mar 20, 2026, STOK was evaluated by Sumant Kulkarni, who gave a Buy rating and target of 60. Investors saw limited payoff as shares fell short of the 60 target.

MPLT

Mar 19, 2026

Target

$35.00

Current

$37.22

Performance

112.81%

Sumant Kulkarni rated MPLT as Buy on Mar 19, 2026, setting a price target of 35. The call has proven timely, with shares rising 112.81% toward the price target of 35.

CLNN

Mar 13, 2026

Target

$48.00

Current

$5.69

Performance

-0.52%

On Mar 13, 2026, CLNN was given a Buy rating by Sumant Kulkarni, with a target price of 48. The stock traded sideways with a -0.52% move, keeping the bullish thesis unresolved.

GHRS

Jan 06, 2026

Target

$39.00

Current

$29.13

Performance

106.30%

GHRS received a Buy rating from Sumant Kulkarni on Jan 06, 2026, aiming for 39. Momentum has favored the Buy call, with shares climbing from 29.13 to 29.13, rewarding those who trusted the recommendation.

CYBN

Nov 20, 2025

Target

$45.00

Current

$8.28

Performance

41.54%

On Nov 20, 2025, Sumant Kulkarni published a Buy outlook on CYBN, with a target of 45. Shares gained 41.54%, underscoring the accuracy of the bullish outlook toward 45.

MNMD

Nov 07, 2025

Target

$25.00

Current

$20.69

Performance

76.84%

Sumant Kulkarni on Nov 07, 2025 assigned MNMD a Buy rating, with a price target of 25. The Buy call aligned well with market performance, producing a gain of 76.84%.

CRVO

Jul 29, 2025

Target

$27.00

Current

$3.14

Performance

-62.71%

On Jul 29, 2025, Sumant Kulkarni reaffirmed CRVO with a Buy rating, targeting 27. Shares slid 62.71% despite the recommendation, highlighting downside risks.

SAGE

Jun 17, 2025

Target

$8.50

Current

$8.68

Performance

-4.82%

SAGE was rated Hold by Sumant Kulkarni on Jun 17, 2025, with a price objective of 8.5. Flat performance suggests the Hold view was reasonable.

VYGR

Mar 13, 2025

Target

$12.00

Current

$3.04

Performance

-25.31%

On Mar 13, 2025, Sumant Kulkarni initiated coverage on VYGR with a Buy rating and target of 12. The Buy call has yet to be validated as shares remain 8.96 away from the target.

ITCI

Jan 31, 2025

Target

$132.00

Current

$131.87

Performance

3.77%

Sumant Kulkarni issued a Hold recommendation for ITCI on Jan 31, 2025, price target set at 132. The rating was appropriate for a consolidating market trading near 131.87.

BTAI

Jan 06, 2025

Target

$5.00

Current

$0.87

Performance

-90.51%

On Jan 06, 2025, BTAI was evaluated by Sumant Kulkarni, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

Frequency Asked Questions

Who is Sumant Kulkarni?

Sumant Kulkarni is an analyst from Canaccord Genuity specializing in the Healthcare sector.

What is Sumant Kulkarni's success rate?

Sumant Kulkarni currently has a success rate of +81.96%.

How many ratings has Sumant Kulkarni issued?

Sumant Kulkarni has issued 32 stock ratings so far.

What is the average return of Sumant Kulkarni's calls?

Their stock ratings have generated an average return of +35.69%.

What is Sumant Kulkarni's ranking?

Sumant Kulkarni is ranked #704 out of 4728 analysts.

What types of ratings does Sumant Kulkarni give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Sumant Kulkarni?

You can follow Sumant Kulkarni by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Sumant Kulkarni?

Their latest rating was a Hold on ATAI issued on 2026-07-16.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep